Summary The International Initiative on Thrombosis and Cancer is an independent
academic working group of experts aimed at establishing global consensus for the treatment …

Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Thromboembolism in people with cancer still remains a major health problem and is a
leading cause of mortality after cancer itself, despite being a largely preventable disease. 1 …

Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

PURPOSE To conduct an update of the ASCO venous thromboembolism (VTE) guideline.
METHODS After publication of potentially practice-changing clinical trials, identified through …

Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

These guidelines are dedicated to the memory of Dr Clive Kearon of McMaster University in
Hamilton, Ontario, Canada. Dr Kearon extensively reviewed the first and second versions of …

Importance In patients with cancer who have venous thromboembolism (VTE) events, long-
term anticoagulation with low-molecular-weight heparin (LMWH) is recommended to prevent …

Direct oral anticoagulants (DOAC s) have quickly become attractive alternatives to the long‐
standing standard of care in anticoagulation, vitamin K antagonist. DOAC s are indicated for …